SCTX insider transaction filings
Scribe Therapeutics, Inc. — 13 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-29. Screen SCTX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-29 | 4 | AH Bio Fund II, L.P. — 10% owner AH Equity Partners Bio II, L.L.C. — 10% owner AH Bio Fund III, L.P. — 10% owner AH Equity Partners Bio III, L.L.C. — 10% owner Andreessen Marc L — 10% owner HOROWITZ BENJAMIN A — 10% owner | Conversion (C): 2,051,742 · Conversion (C): 697,650 · Purchase (P): 333,333 @ $15 · Conversion (C): 12,150,003 (derivative) @ $0 · Conversion (C): 4,131,344 (derivative) @ $0 | EDGAR |
| 2026-07-29 | 4 | GORDON CARL L — Director | Conversion (C): 348,825 · Purchase (P): 1,000,000 @ $15 · Conversion (C): 2,065,672 (derivative) @ $0 | EDGAR |
| 2026-07-29 | 4 | ORBIMED ADVISORS LLC — Director OrbiMed Capital GP VIII LLC — Director | Conversion (C): 348,825 · Purchase (P): 1,000,000 @ $15 · Conversion (C): 2,065,672 (derivative) @ $0 | EDGAR |
| 2026-07-29 | 4 | Doudna Jennifer A — 10% owner | Conversion (C): 12,511 · Conversion (C): 74,088 (derivative) | EDGAR |
| 2026-07-28 | 4 | Aghazadeh Behzad — Director, 10% owner Avoro Capital Advisors LLC — Director, 10% owner Avoro Ventures LLC — Director | Purchase (P): 2,333,333 @ $15 · Purchase (P): 50,000 @ $22.31 · Purchase (P): 7,905 @ $18.25 | EDGAR |
| 2026-07-28 | 4 | Staahl Brett — 10% owner | Grant/award (A): 4,755 (derivative) @ $0 · Grant/award (A): 19,385 (derivative) @ $0 · Grant/award (A): 19,385 (derivative) @ $0 | EDGAR |
| 2026-07-27 | 4 | Lucas Svetlana — Chief Business Officer | Purchase (P): 3,000 @ $15 · Grant/award (A): 9,547 (derivative) @ $0 · Grant/award (A): 109,426 (derivative) @ $0 · Grant/award (A): 109,426 (derivative) @ $0 | EDGAR |
| 2026-07-27 | 4 | GORDON CARL L — Director | Grant/award (A): 14,725 (derivative) @ $0 | EDGAR |
| 2026-07-27 | 4 | Oakes Benjamin L. — President, CEO, Director | Grant/award (A): 12,969 (derivative) @ $0 · Grant/award (A): 264,784 (derivative) @ $0 · Grant/award (A): 429,599 (derivative) @ $0 | EDGAR |
| 2026-07-27 | 4 | Watson James Dean — Director | Grant/award (A): 14,725 (derivative) @ $0 | EDGAR |
| 2026-07-27 | 4 | Bleharski Joshua — Director | Grant/award (A): 14,725 (derivative) @ $0 | EDGAR |
| 2026-07-27 | 4 | Parrot David — Chief Financial Officer | Purchase (P): 1,333 @ $15 · Purchase (P): 1,333 @ $15 · Grant/award (A): 8,909 (derivative) @ $0 · Grant/award (A): 109,426 (derivative) @ $0 · Grant/award (A): 109,426 (derivative) @ $0 | EDGAR |
| 2026-07-27 | 4 | Aghazadeh Behzad — Director Avoro Capital Advisors LLC — Director Avoro Ventures LLC — Director | Grant/award (A): 14,725 (derivative) @ $0 | EDGAR |
Recent 8-K events — Scribe Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-27 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=SCTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →